489
Views
13
CrossRef citations to date
0
Altmetric
Review

Insights into endotoxin-mediated lung inflammation and future treatment strategies

ORCID Icon, , , &
Pages 941-955 | Received 25 Feb 2018, Accepted 10 Sep 2018, Published online: 03 Oct 2018

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Naif A Al-Gabri, Sultan A M Saghir, Sallah A Al-Hashedi, Ali H El-Far, Asmaa F Khafaga, Ayman A Swelum, Abdullah S Al-wajeeh, Shaker A Mousa, Mohamed E Abd El-Hack, Mohammed A E Naiel & Khaled A El-Tarabily. (2021) Therapeutic Potential of Thymoquinone and Its Nanoformulations in Pulmonary Injury: A Comprehensive Review. International Journal of Nanomedicine 16, pages 5117-5131.
Read now

Articles from other publishers (12)

Petra Labohá, Eliška Sychrová, Ondřej Brózman, Iva Sovadinová, Lucie Bláhová, Roman Prokeš, Jakub Ondráček & Pavel Babica. (2023) Cyanobacteria, cyanotoxins and lipopolysaccharides in aerosols from inland freshwater bodies and their effects on human bronchial cells. Environmental Toxicology and Pharmacology 98, pages 104073.
Crossref
Kevin Serey, Amélie Cambriel, Adrien Pollina-Bachellerie, Jean-Pierre Lotz & François Philippart. (2022) Advance Directives in Oncology and Haematology: A Long Way to Go—A Narrative Review. Journal of Clinical Medicine 11:5, pages 1195.
Crossref
Wenqi Chen, Shanshan Chen, Lifang Zhao, Mei Zhang, Hong Geng, Chuan Dong & Ruijin Li. (2022) Effects of real-ambient PM 2.5 exposure plus lipopolysaccharide on multiple organ damage in mice . Human & Experimental Toxicology 41, pages 096032712110615.
Crossref
Chenliang Zhou, Bo Peng, Zhenghui Qin, Wei Zhu & Cuiping Guo. (2021) Metformin attenuates LPS-induced neuronal injury and cognitive impairments by blocking NF-κB pathway. BMC Neuroscience 22:1.
Crossref
Meenu Mehta, Keshav Raj Paudel, Shakti Dhar Shukla, Venkata Sita Rama Raju Allam, Vinod Kumar Kannaujiya, Nisha Panth, Amlan Das, Vipan Kumar Parihar, Amlan Chakraborty, Md Khadem Ali, Niraj Kumar Jha, Dikaia Xenaki, Qian Peter Su, Peter Richard Wich, Jon Adams, Philip Michael Hansbro, Dinesh Kumar Chellappan, Brian Gregory George Oliver & Kamal Dua. (2021) Recent trends of NFκB decoy oligodeoxynucleotide-based nanotherapeutics in lung diseases. Journal of Controlled Release 337, pages 629-644.
Crossref
Amlan Chakraborty, Anita A. Pinar, Maggie Lam, Jane E. Bourke, Simon G. Royce, Cordelia Selomulya & Chrishan S. Samuel. (2021) Pulmonary myeloid cell uptake of biodegradable nanoparticles conjugated with an anti-fibrotic agent provides a novel strategy for treating chronic allergic airways disease. Biomaterials 273, pages 120796.
Crossref
Haiyan He, Yaoying Ma, Huaxing Huang, Chao Huang, Zhuo Chen, Dongjian Chen, Yiming Gu, Xiaohua Wang & Jinliang Chen. (2021) A comprehensive understanding about the pharmacological effect of diallyl disulfide other than its anti-carcinogenic activities. European Journal of Pharmacology 893, pages 173803.
Crossref
Sheena E. Martenies, Joshua W. Schaeffer, Grant Erlandson, Mary Bradford, Jill A. Poole, Ander Wilson, Zachary Weller, Stephen J. Reynolds & Sheryl Magzamen. (2020) Associations Between Bioaerosol Exposures and Lung Function Changes Among Dairy Workers in Colorado. Journal of Occupational & Environmental Medicine 62:6, pages 424-430.
Crossref
Amlan Chakraborty, Simon Royce, Cordelia Selomulya & Magdalena Plebanski. (2020) A Novel Approach for Non-Invasive Lung Imaging and Targeting Lung Immune Cells. International Journal of Molecular Sciences 21:5, pages 1613.
Crossref
Amlan Chakraborty & Cordelia Selomulya. 2020. Targeting Chronic Inflammatory Lung Diseases Using Advanced Drug Delivery Systems. Targeting Chronic Inflammatory Lung Diseases Using Advanced Drug Delivery Systems 303 321 .
Amlan Chakraborty & Cordelia Selomulya. 2020. Targeting Chronic Inflammatory Lung Diseases Using Advanced Drug Delivery Systems. Targeting Chronic Inflammatory Lung Diseases Using Advanced Drug Delivery Systems 261 280 .
Amlan Chakraborty & Simon G. Royce. 2020. Targeting Chronic Inflammatory Lung Diseases Using Advanced Drug Delivery Systems. Targeting Chronic Inflammatory Lung Diseases Using Advanced Drug Delivery Systems 97 115 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.